12/15-Lipoxygenase Is an Interleukin-13 and Interferon-γ Counterregulated-Mediator of Allergic Airway Inflammation

Interleukin-13 and interferon-γ are important effectors of T-helper cells. Interleukin-13 increases expression of the arachidonic acid-metabolizing enzyme, 15-lipoxygenase-1, in a variety of cell types. 15-lipoxygenase-1 is dramatically elevated in the airways of subjects with asthma. Studies in ani...

Full description

Saved in:
Bibliographic Details
Main Authors: Alexa R. Lindley, Margaret Crapster-Pregont, Yanjun Liu, Douglas A. Kuperman
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2010/727305
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832545430454403072
author Alexa R. Lindley
Margaret Crapster-Pregont
Yanjun Liu
Douglas A. Kuperman
author_facet Alexa R. Lindley
Margaret Crapster-Pregont
Yanjun Liu
Douglas A. Kuperman
author_sort Alexa R. Lindley
collection DOAJ
description Interleukin-13 and interferon-γ are important effectors of T-helper cells. Interleukin-13 increases expression of the arachidonic acid-metabolizing enzyme, 15-lipoxygenase-1, in a variety of cell types. 15-lipoxygenase-1 is dramatically elevated in the airways of subjects with asthma. Studies in animals indicate that 15-lipoxygenase-1 contributes to the development of allergic airway inflammation but is protective in some other forms of inflammation. We tested the hypothesis that the ability of interleukin-13 and interferon-γ to counterregulate allergic airway inflammation was potentially mediated by counterregulation of 12/15-lipoxygenase, the mouse ortholog of 15-lipoxygenase-1. The airways of mice were treated with interleukin-13 or interferon-γ one day prior to each of the four allergen exposures. Interleukin-13 augmented and interferon-γ inhibited allergic airway inflammation independently of systemic IgE and mucosal IgA responses but in association with counterregulation of 12/15-lipoxygenase. Interleukin-13 and interferon-γ counterregulate 12/15-lipoxygenase potentially contributing to the effects of these cytokines on allergic airway inflammation.
format Article
id doaj-art-4fcfdcc696274a71b2d1114abdc6972f
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-4fcfdcc696274a71b2d1114abdc6972f2025-02-03T07:25:47ZengWileyMediators of Inflammation0962-93511466-18612010-01-01201010.1155/2010/72730572730512/15-Lipoxygenase Is an Interleukin-13 and Interferon-γ Counterregulated-Mediator of Allergic Airway InflammationAlexa R. Lindley0Margaret Crapster-Pregont1Yanjun Liu2Douglas A. Kuperman3Allergy-Immunology Division, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USAAllergy-Immunology Division, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USAAllergy-Immunology Division, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USAAllergy-Immunology Division, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USAInterleukin-13 and interferon-γ are important effectors of T-helper cells. Interleukin-13 increases expression of the arachidonic acid-metabolizing enzyme, 15-lipoxygenase-1, in a variety of cell types. 15-lipoxygenase-1 is dramatically elevated in the airways of subjects with asthma. Studies in animals indicate that 15-lipoxygenase-1 contributes to the development of allergic airway inflammation but is protective in some other forms of inflammation. We tested the hypothesis that the ability of interleukin-13 and interferon-γ to counterregulate allergic airway inflammation was potentially mediated by counterregulation of 12/15-lipoxygenase, the mouse ortholog of 15-lipoxygenase-1. The airways of mice were treated with interleukin-13 or interferon-γ one day prior to each of the four allergen exposures. Interleukin-13 augmented and interferon-γ inhibited allergic airway inflammation independently of systemic IgE and mucosal IgA responses but in association with counterregulation of 12/15-lipoxygenase. Interleukin-13 and interferon-γ counterregulate 12/15-lipoxygenase potentially contributing to the effects of these cytokines on allergic airway inflammation.http://dx.doi.org/10.1155/2010/727305
spellingShingle Alexa R. Lindley
Margaret Crapster-Pregont
Yanjun Liu
Douglas A. Kuperman
12/15-Lipoxygenase Is an Interleukin-13 and Interferon-γ Counterregulated-Mediator of Allergic Airway Inflammation
Mediators of Inflammation
title 12/15-Lipoxygenase Is an Interleukin-13 and Interferon-γ Counterregulated-Mediator of Allergic Airway Inflammation
title_full 12/15-Lipoxygenase Is an Interleukin-13 and Interferon-γ Counterregulated-Mediator of Allergic Airway Inflammation
title_fullStr 12/15-Lipoxygenase Is an Interleukin-13 and Interferon-γ Counterregulated-Mediator of Allergic Airway Inflammation
title_full_unstemmed 12/15-Lipoxygenase Is an Interleukin-13 and Interferon-γ Counterregulated-Mediator of Allergic Airway Inflammation
title_short 12/15-Lipoxygenase Is an Interleukin-13 and Interferon-γ Counterregulated-Mediator of Allergic Airway Inflammation
title_sort 12 15 lipoxygenase is an interleukin 13 and interferon γ counterregulated mediator of allergic airway inflammation
url http://dx.doi.org/10.1155/2010/727305
work_keys_str_mv AT alexarlindley 1215lipoxygenaseisaninterleukin13andinterferongcounterregulatedmediatorofallergicairwayinflammation
AT margaretcrapsterpregont 1215lipoxygenaseisaninterleukin13andinterferongcounterregulatedmediatorofallergicairwayinflammation
AT yanjunliu 1215lipoxygenaseisaninterleukin13andinterferongcounterregulatedmediatorofallergicairwayinflammation
AT douglasakuperman 1215lipoxygenaseisaninterleukin13andinterferongcounterregulatedmediatorofallergicairwayinflammation